1. Home
  2. CDLX vs ADVB Comparison

CDLX vs ADVB Comparison

Compare CDLX & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$1.27

Market Cap

10.1M

Sector

Technology

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

SELL

Current Price

$2.20

Market Cap

8.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CDLX
ADVB
Founded
2008
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.6M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
CDLX
ADVB
Price
$1.27
$2.20
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $4.43
N/A
AVG Volume (30 Days)
61.1K
★ 77.0K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
50.13
★ 3431.25
EPS
N/A
★ N/A
Revenue
★ $233,273,000.00
$127,637.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.53
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.55
$1.80
52 Week High
$6.40
$113.80

Technical Indicators

Market Signals
Indicator
CDLX
ADVB
Relative Strength Index (RSI) 27.28 36.17
Support Level $0.85 $1.80
Resistance Level $2.32 $5.59
Average True Range (ATR) 0.19 0.53
MACD -0.01 0.17
Stochastic Oscillator 2.83 20.47

Price Performance

Historical Comparison
CDLX
ADVB

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: